Skip to content

Impact of Vitamin D2-enhanced mushrooms on vitamin D concentration and Insulin Resistance

Impact of Ergocalciferol-enhanced Mushrooms on Vitamin D Concentration and Insulin Resistance: A Randomized, Single-Blind Study in Vitamin D Deficient, Overweight, or Obese Young Adults in Bangalore, India. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076492
Enrollment
90
Registered
2024-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Arm 2 â??600 IU/d enhanced dried mushroom powder: Cookies and cutlets incorporated with enhanced dried mushroom powder (600 IU) Frequency is daily Total Duration - 12 weeks (3 months)

Sponsors

Dr. Pratibha Dwarkanath
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Young adults of both sexes aged 18 to 30 years who are overweight or obese with BMI more than 24.9 kg/m2 will be included in the study. 2. Vitamin D deficiency on screening with serum vitamin D levels less than 20 ng/mL or 50 nmol/L. 3. Participants willing to consume vitamin D2 enhanced mushroom powder in the form of home based snacks daily for 3 months. 4. Participants willing to undergo blood collection of 5 mL venous blood at three time points for evaluation of vitamin D status, total vitamin D, vitamin D2, vitamin D3, PTH and OGTT profile including fasting, 1 hour, 2 hour and 3 hour blood samples at baseline, 3 months after intervention and 3.5 months. Urine collection for calcium and creatinine ratio will be done at 1.5 months.

Exclusion criteria

Exclusion criteria: 1)Participants with mushroom food allergy, severe anemia. 2)Participants who are underweight (BMI less than 18.5 kg/m2) and normal (BMI: 18.5 â?? 24.9 kg/m2) will be excluded and consuming vitamin D tablets or tablets which may influence vitamin D absorption. 3) Abnormal biochemical parameters of liver and kidney function tests. 4) Discontinue the supplementation regime before the completion of the study/ move out of the study site

Design outcomes

Primary

MeasureTime frame
Primary outcome name: Change in total vitamin D serum level and insulin resistance, time point: 3 months (12 weeks).Timepoint: 3 months (12 weeks).

Secondary

MeasureTime frame
Assessing the delta change in serum vitamin D2 and vitamin D3 forms and PTH levels.Timepoint: 3 months (12 weeks)

Countries

India

Contacts

Public ContactDr Pratibha Dwarkanath

St. Johnâ??s Research Institute

pratibha@sjri.res.in9880714118

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026